CelSci (CVM)
(Real Time Quote from BATS)
$1.45 USD
-0.02 (-1.36%)
Updated Apr 24, 2024 03:50 PM ET
After-Market: $1.45 0.00 (0.00%) 4:08 PM ET
NA Value
NA Growth NA Momentum NA VGMCel-Sci (CVM) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$7.00 | $7.00 | $7.00 | 376.19% |
Price Target
Only one analyst offered a short-term price target of $7.00 for Cel-Sci. This represents an increase of 376.19% from the last closing price of $1.47.
Analyst Price Targets (1 )
Broker Rating
Cel-Sci does not currently have any recommendation from brokerage firms.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | NA | NA | NA | NA | NA |
Buy | NA | NA | NA | NA | NA |
Hold | NA | NA | NA | NA | NA |
Sell | NA | NA | NA | NA | NA |
Strong Sell | NA | NA | NA | NA | NA |
ABR | NA | NA | NA | NA | NA |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
Not Identified | Not Identified | Not Identified | Not Identified | Not Identified |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | NA |
ABR (Last week) | NA |
# of Recs in ABR | NA |
Average Target Price | $7.00 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 78 of 252 |
Current Quarter EPS Est: | -0.14 |